Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 406-850-2 | CAS number: 133855-98-8 BAS 480 F
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Dermal absorption
Administrative data
- Endpoint:
- dermal absorption in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Oct 1988 - May 1991
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Cross-reference
- Reason / purpose for cross-reference:
- reference to same study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 991
- Report date:
- 1991
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: EPA/FIFRA Guideline, Section 40 CFR 158.135, 85-2 and Section 40 CFR 795, Subpart D
- GLP compliance:
- yes (incl. QA statement)
Test material
- Reference substance name:
- (2RS,3RS)-3-(2-chlorophenyl)-2-(4-fluorophenyl)-[(1H-1,2,4-triazol-1-yl)methyl]oxirane
- EC Number:
- 406-850-2
- EC Name:
- (2RS,3RS)-3-(2-chlorophenyl)-2-(4-fluorophenyl)-[(1H-1,2,4-triazol-1-yl)methyl]oxirane
- Cas Number:
- 133855-98-8
- Molecular formula:
- C17 H13 Cl F N3 O
- IUPAC Name:
- 1-{[(2R,3R)-3-(2-chlorophenyl)-2-(4-fluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazole
Constituent 1
- Radiolabelling:
- yes
Test animals
- Species:
- rat
- Strain:
- Fischer 344
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Kleintierfarm Madoerin AG, Ch-4414 Fuellinsdorf/Switzerland
- Age at study initiation: not specified
- Weight at study initiation: about 200-250 g
- Housing:groups of 2-3
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19-25
- Humidity (%): 40-70
- Air changes (per hr): 10-15
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Type of coverage:
- occlusive
- Vehicle:
- methylcellulose
- Duration of exposure:
- max 10 h. (0.5, 1, 2, 4, 10 h)
- Doses:
- - 3 mg/kg bw
- 30 mg/kg bw - No. of animals per group:
- 4
- Control animals:
- no
- Details on study design:
- DOSE PREPARATION
- Method for preparation of dose suspensions: Preparation of two stock solutions. Respective aliquots were based on the intended dose levels of 3.0 mg/kg and 30.0 mg/kg. Assuming a rat body weight of 250 g, these quantities would correspond to 0.75 mg/15 cm² rat skin and 7.5 mg/15 cm² rat skin, respectively.
- Method of storage: Stock solutions stored at -20 degrees celsius
APPLICATION OF DOSE: about 800 µl per rat
TEST SITE
- Preparation of test site: shaved
- Area of exposure: back
- Treated area: 15 cm²
- Type of cover / wrap if used: occlusive (except for rats exposed to 0.5 h. They had no gauze or bandage)
- Time intervals for shavings or clipplings: adminsitration of test substance once
SITE PROTECTION / USE OF RESTRAINERS FOR PREVENTING INGESTION: not specified
REMOVAL OF TEST SUBSTANCE
- Removal of protecting device: after max 10 h
- Washing procedures and type of cleansing agent: yes, soap-solution and water
- Time after start of exposure: max 10 h
- Duration of recovery: 0.5, 1, 2, 4, 10, and 72 h after termination of the treatment
SAMPLE COLLECTION
- Collection of blood: yes
- Collection of urine and faeces: yes
- Collection of expired air: no
- Analysis of organs: yes; treated skin, liver, kidney, GIT (with contents), and residual carcass.
ANALYSIS
- Method type(s) for identification: Liquid scintillation counting, TLC,
- Liquid scintillation counting results (cpm) converted to dpm as follows: not applicable
Results and discussion
- Signs and symptoms of toxicity:
- no effects
- Dermal irritation:
- no effects
- Absorption in different matrices:
- At the low dose level, only small amounts of radioactivity were absorbed. Total absorbed radioactivity was similar at all time intervals and ranged from 5.82 % to 9.44%. The significant difference (0.01 Total excreted radioactivity up to 10 hours ranged from <0.01% (1 hour) to 0.21 % (10 hours). After 72 hours, total excreted radioactivity amounted to 3.17%. The increase was mainly due to an increase in fecal excretion (2.25 %) as compared to the amount of urinary excretion (0.84%) and cage-wash (0.08%).
The major part of the fecal radioactivity was excreted within the first 38 hours after the 10 hours dermal exposure period.
Except for 72 hours, the amount of radioactivity totally absorbed reflected mainly the amount of radioactivity remaining in the treated skin after skinwash and ranged from 4.80 % (4 hours) to 7.12 % (10 hours). After 72 hours, radioactivity in the treated skin was reduced to 2.02 %.
In liver, kidney, gastro—intestinal tract (with contents) and blood, only small amounts of radioactivity were found, ranging from (0.01% to 0.36 %. Only the residual carcass showed somewhat higher levels, ranging from 0.32 % to 1.51 %.
At a ten times higher dose level, total absorbed radioactivity ranged from 9.57 % to 20.06 % at all time intervals. As compared to the low dose level, only about 2 times higher amounts were absorbed from 2 to 72 hours. The significant difference (0.002 Total excreted radioactivity up to 10 hours ranged from <0.01 % (0.5 hours) to 0.13 % (10 hours). After 72 hours, totaT excreted radioactivity amounted to 5.76 %. Again, the increase was mainly due to an increase in fecal excretion (4.25 %) as compared to urinary excretion (1.22 %) and cage-wash (0.29 %).
The major part of fecal radioactivity was excreted within 38 hours after the 10 hours dermal exposure period, although still a sign1ficant amount (1.53 %) was excreted from 48 to 72 hours (Table 15).
Except for 72 hours, the amount of radioactivity totally absorbed reflected mainly the amount of radioactivity remaining in the treated skin after skinwash, ranging from 7.26 % to 18.21 %. From 10 hours to 72 hours, radioactivity in the treated skin was reduced from 16.08 % to 5.10 %. In liver, kidney, gastro-intestinal tract (with contents) and blood, only small amounts of radioactivity were found, ranging from (0.01 % to 0.79 %. Only the residual carcass showed somewhat higher levels, ranging from 1.09 %
to 2.34% .
In conclusion, at both dose levels only small amounts of radioactivity were absorbed during 10 hours of dermal exposure. The increased amount of radioactivity excreted and the simultaneously decrease of radioactivity in the treated skin from 10 to 72 hours, indicated that the test substance was further absorbed and eliminated after 10 hours of dermal exposure. - Total recovery:
- Total mean recoveries for both dose levels at all time intervals ranged from 96.55% to 106.19%. The complete recoveries indicate that - except for the quantity absorbed - other routes of loss could be excluded.
Percutaneous absorptionopen allclose all
- Time point:
- 72 h
- Dose:
- 3 mg/kg bw
- Parameter:
- percentage
- Absorption:
- >= 0.014 - <= 4.519 other: µg/g
- Remarks on result:
- other: Radioactivity level in plasma, blood, treated skin, liver, kidney, GIT, and residual carcass.
- Time point:
- 72 h
- Dose:
- 30 mg/kg bw
- Parameter:
- percentage
- Absorption:
- >= 0.12 - <= 129.64 other: µg/g
- Remarks on result:
- other: Radioactivity level in plasma, blood, treated skin, liver, kidney, GIT, and residual carcass.
Any other information on results incl. tables
In conclusion, at the dose level of 3.0 mg/kg, highest residual radioactivity levels were found at 10 hours of dermal exposure in treated skin, liver and gastro-intestinal tract. After 72 hours, except for blood, all radioactivity levels decreased. Accordingly, significant amounts of radioactivity were excreted via urine and feces from 10 to 72 hours.
In conclusion, at the dose level of 30.0 mg/kg, except for the 2-fold reduction of radioactivity levels in treated skin and residual carcass, all levels were higher at 72 hours as compared to 10 hours, indicating that elimination of radioactivity was not compIete at the last time interval. Accordingly, significant amounts of radioactivity were still excreted in urine and feces from 48 to 72 hours. Taking into account the about 5 times higher LOQ-values at the high dose at about 10 times higher dose levels, except for treated skin and gastro-intestinal tract with contents, maximal residual radioactivity levels in organs/tissues increased 6 to 14 times. In the blood, only a twofold increase was found.
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.